The company maintains a healthy liquidity position with a current ratio of 2.20 as of 2027Q1, though the equity base remains pressured by a persistent accumulated deficit of $1.7 billion.
| Total Current Assets | 1.83B | 2.24B | 2.34B | 2.58B | 2.34B | 2.28B | 734.43M | 400.98M |
| Cash & Short-Term Investments | 1.31B | 1.47B | 1.63B | 1.88B | 1.76B | 1.87B | 460.52M | 232.39M |
| Cash Only | 633.67M | 871.16M | 879.63M | 1.06B | 1.4B | 1.77B | 357.69M | 232.39M |
| Short-Term Investments | 675.05M | 601.33M | 750.32M | 818.14M | 354.77M | 96.42M | 102.83M | 0 |
| Accounts Receivable | 410.23M | 580.71M | 542.27M | 523.79M | 446.98M | 336.89M | 217.69M | 118.31M |
| Days Sales Outstanding | 102.37 | 131.6 | 138.44 | 146.16 | 154.12 | 137.82 | 130.76 | 128.47 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 112.78M | 190.75M | 101M | 88.58M | 72.74M | 29.93M | 17.65M | 21.11M |
| Total Non-Current Assets | 1.07B | 935.25M | 526.71M | 374.35M | 390.8M | 295.15M | 132.03M | 107.19M |
| Property, Plant & Equipment | 112M | 110.49M | 99.24M | 80.05M | 81.1M | 66.13M | 32.08M | 43.58M |
| Fixed Asset Turnover | 15.22x | 14.58x | 14.41x | 16.34x | 13.05x | 13.49x | 18.94x | 7.71x |
| Goodwill | 185.69M | 125.31M | 87.3M | 89.03M | 88.01M | 53.56M | 28.06M | 25.31M |
| Intangible Assets | 100.12M | 19.99M | 7.91M | 14.7M | 23.01M | 16.82M | 10.19M | 11.78M |
| Long-Term Investments | 315.55M | 0 | 130.41M | 1.5M | 2.94M | 19.52M | 0 | 122K |
| Other Non-Current Assets | 314.19M | 446.07M | 173.89M | 184.38M | 189.84M | 128.49M | 53.58M | 26.52M |
| Total Assets | 2.9B | 3.18B | 2.87B | 2.95B | 2.74B | 2.57B | 866.46M | 508.17M |
| Asset Turnover | 0.58x | 0.51x | 0.50x | 0.44x | 0.39x | 0.35x | 0.70x | 0.66x |
| Asset Growth % | 25.5% | 10.96% | -3.03% | 8.03% | 6.33% | 196.89% | 70.51% | - |
| Total Current Liabilities | 831.67M | 905.42M | 798.92M | 711.69M | 626.45M | 527.5M | 365.16M | 238.62M |
| Accounts Payable | 19.7M | 10.16M | 33.18M | 3.45M | 8.89M | 11.52M | 6.68M | 4.61M |
| Days Payables Outstanding | 20.46 | 13.53 | 49.04 | 6.42 | 18.02 | 24.89 | 37.03 | 28.31 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 2.22B | 603.74M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 178.69M | 291.52M | 604.78M | 531.37M | 434.55M | 345.68M | 218.88M | 152.22M |
| Current Ratio | 2.20x | 2.48x | 2.93x | 3.63x | 3.74x | 4.32x | 2.01x | 1.68x |
| Quick Ratio | 2.20x | 2.48x | 2.93x | 3.63x | 3.74x | 4.32x | 2.01x | 1.68x |
| Cash Conversion Cycle | 81.91 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 170.07M | 191.19M | 220.59M | 226.95M | 188.6M | 123.03M | 83.04M | 72.67M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 287.57M | 70.94M | 74.23M | 58.71M | 56.44M | 49.84M | 14.15M | 20.39M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 338K | 34K | 0 | 0 |
| Other Non-Current Liabilities | 11.9M | 16.68M | 10.52M | 7.21M | 10.46M | 4.52M | 68.89M | 52.28M |
| Total Liabilities | 1B | 1.1B | 1.02B | 938.64M | 815.05M | 650.53M | 448.2M | 311.29M |
| Total Debt | 71.99M | 70.94M | 77.82M | 67.07M | 63.44M | 51.4M | 20.08M | 26.25M |
| Net Debt | -561.68M | -800.22M | -801.38M | -994.61M | -1.34B | -1.72B | -337.61M | -206.13M |
| Debt / Equity | 0.04x | 0.03x | 0.04x | 0.03x | 0.03x | 0.03x | 0.05x | 0.13x |
| Debt / EBITDA | 0.58x | 0.91x | - | - | - | - | - | - |
| Net Debt / EBITDA | -4.50x | -10.27x | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - |
| Total Equity | 1.9B | 2.08B | 1.85B | 2.02B | 1.92B | 1.92B | 418.26M | 196.88M |
| Equity Growth % | 26.85% | 12.83% | -8.45% | 5% | -0.09% | 359.5% | 112.45% | - |
| Book Value per Share | 3.61 | 3.82 | 3.30 | 3.58 | 3.50 | 3.55 | 0.81 | 0.38 |
| Total Shareholders' Equity | 1.9B | 2.08B | 1.85B | 2.02B | 1.92B | 1.92B | 418.26M | 196.88M |
| Common Stock | 6K | 6K | 6K | 6K | 6K | 5K | 2K | 1K |
| Retained Earnings | -1.68B | -1.71B | -1.99B | -1.91B | -1.82B | -1.5B | -970.36M | -877.97M |
| Treasury Stock | -1.07B | -833.9M | -494.78M | -102.61M | 0 | 0 | 0 | 0 |
| Accumulated OCI | 27.37M | 36.6M | -4.89M | 8.82M | 7.61M | 10.9M | -12.52M | 6.23M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Competitive Agentic AI Disruption
As reported in recent financial filings, UiPath's total assets have contracted from $3.2 billion in 2026Q4 to $2.9 billion in 2027Q1, reflecting a shift in the company's capital base as it navigates a more mature phase of enterprise software penetration and competitive market pressures.
The reduction in total assets suggests a potential optimization of the balance sheet as the company moves away from aggressive expansion. Investors should monitor whether this contraction indicates a disciplined approach to asset management or a cooling of the underlying business momentum.
Based on the provided balance sheet data, UiPath maintains a current ratio of 2.20 as of 2027Q1, which, while down from the 4.13 peak in 2025Q1, continues to provide a substantial liquidity buffer against near-term operational volatility and potential shifts in enterprise IT spending cycles.
The company's ability to maintain a current ratio well above 2.0 suggests that it remains well-positioned to meet its short-term obligations without immediate reliance on external financing. This liquidity profile provides management with the flexibility to continue investing in R&D despite the ongoing challenges in achieving consistent GAAP profitability.
According to historical balance sheet figures, UiPath's equity base remains pressured by a persistent accumulated deficit of $1.7 billion as of 2027Q1, highlighting the long-term impact of heavy R&D and sales-related investments on the company's overall shareholder equity position.
The stagnant nature of the accumulated deficit suggests that the company has yet to reach a sustainable inflection point where operational profits begin to meaningfully offset historical losses. This warrants further investigation into the long-term efficacy of the company's current capital allocation strategy regarding stock-based compensation and dilution.
As indicated by recent financial statements, UiPath's deferred revenue balance of $658.2 million in 2027Q1 represents a significant liability that underscores the company's reliance on multi-year subscription contracts to drive future revenue recognition and long-term customer retention.
While this deferred revenue provides a degree of forward visibility, it also represents a future performance obligation that must be fulfilled to avoid potential churn. The fluctuation in these balances suggests that the timing of large enterprise renewals remains a critical variable in the company's quarterly financial performance.
Quick answers to the most common questions about buying PATH stock.
As of 2026, UiPath Inc. (PATH) had total assets of $3.18B including $2.24B in current assets.
UiPath Inc. (PATH) carries total debt of $70.9M, offset by $1.47B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
UiPath Inc. (PATH) has total shareholders' equity (book value) of $2.08B ($3.82 book value per share). Book value represents the net worth of the company belonging to common stock holders.
UiPath Inc. (PATH) reported a current ratio of 2.48x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.